CDC Panel Recommends Pfizer COVID Boosters for Ages 12-15

Jan. 5, 2022 – A CDC advisory panel at this time advisable that 12- to 17-year-olds within the U.S. ought to get the Pfizer COVID-19 booster shot 5 months after a main collection of vaccinations.

The CDC had already mentioned 16- and 17-year-olds “might” obtain a Pfizer booster however at this time’s advice provides the 12-15 group and strengthens the “might” to “ought to” for 16- and 17-year-olds.

The committee voted 13-1 to advocate the booster for ages 12-17.

The vote comes after the FDA on Monday authorized the Pfizer vaccine booster dose for 12- to 15-year-olds.

The FDA motion up to date the authorization for the Pfizer vaccine, and the company additionally shortened the advisable time between a second dose and the booster to five months or extra (from 6 months). A 3rd main collection dose can also be now approved for sure immunocompromised kids between 5 and 11 years previous. Full particulars can be found in an FDA news release.

The CDC on Tuesday additionally backed the shortened time-frame and a 3rd main collection dose for some immunocompromised kids 5 to 11 years previous. However the CDC delayed a choice on a booster for 12- to 15-year-olds till it heard from its Advisory Committee on Immunization Practices at this time.

The choice got here as college districts nationwide are wrestling with selections of whether or not to maintain faculties open or revert to a digital format as instances surge, and as pediatric COVID-19 cases and hospitalizations reach new highs.

Well being Options

Extra from WebMD


The information provided about this medicine is based on the medical literature of the medicine, however, it does not constitute a substitute for consulting a doctor.

Related Articles

Back to top button